Profilo
Olaf Randerath is currently the Head-Medical Affairs at APONTIS PHARMA AG.
Prior to this, he worked as the Head-Development Projects at UCB Pharma GmbH and as the Head-Clinical Development at Schwarz Pharma Deutschland GmbH.
Posizioni attive di Olaf Randerath
| Società | Posizione | Inizio |
|---|---|---|
| APONTIS PHARMA AG | Chief Tech/Sci/R&D Officer | - |
Precedenti posizioni note di Olaf Randerath
| Società | Posizione | Fine |
|---|---|---|
| Schwarz Pharma Deutschland GmbH | Corporate Officer/Principal | - |
UCB Pharma GmbH
 UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| APONTIS PHARMA AG | Health Technology |
| Aziende private | 2 |
|---|---|
UCB Pharma GmbH
UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Health Technology |
| Schwarz Pharma Deutschland GmbH |
- Borsa valori
- Insiders
- Olaf Randerath
